# MoonLake Immunotherapeutics: Form 8-K, filed Apr 3, 2025

- Company: [MoonLake Immunotherapeutics](/companies/mltx.md) (CIK 1821586)
- Form: 8-K
- Filed: 2025-04-03
- Accepted by EDGAR: Apr 3, 2025, 07:05 ET
- Period: 2025-03-31
- Accession: 0001213900-25-028366
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1821586/000121390025028366/ea0236970-8k_moonlake.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1821586/000121390025028366/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1821586/000121390025028366/ea0236970-8k_moonlake.htm

Filed Apr 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-028366. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.